Priapism in Hypogonadal Men Receiving Gonadotropin Releasing Hormone

Whalen, Raymond K.; Whitcomb, Randall W.; Crowley, William F.; McGovern, Francis J.

doi:10.1016/s0022-5347(17)38530-0

Cited by 10 publications

(4 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, androgens have been implicated as an important etiologic factor. There are reports of priapism among men with hypogonadism receiving gonadotropin-releasing hormone or high-dose testosterone, adolescents with SCA receiving testosterone, and men using androstenedione to enhance athletic performance [23][24][25][26]. Table 1 presents a classification of ischemic priapism by etiology, as agreed upon by the AFUD-TLP [1••].…”

Section: Etiology and Epidemiologymentioning

confidence: 99%

The etiology, diagnosis, and treatment of priapism: Review of the American Foundation for Urologic Disease Consensus Panel report

Sadeghi‐Nejad¹,

Seftel

2002

Curr Urol Rep

View full text Add to dashboard Cite

Priapism is an important medical condition that requires immediate evaluation, and depending on etiology, may require emergency management. Based on the classification scheme offered by a recent consensus panel, priapism can be subdivided into ischemic and nonischemic types. The nonischemic type, usually the result of perineal trauma, can be treated with conservative therapy, whereas the nonischemic type, which arises from many varied causes, mandates immediate intervention. Corporal fibrosis and permanent erectile dysfunction can result from ischemic priapism that fails to resolve with therapy.

show abstract

Section: Etiology and Epidemiologymentioning

confidence: 99%

The etiology, diagnosis, and treatment of priapism: Review of the American Foundation for Urologic Disease Consensus Panel report

Sadeghi‐Nejad¹,

Seftel

2002

Curr Urol Rep

View full text Add to dashboard Cite

show abstract

“…44 Ironically, GNRH has also been associated with priapism. 45 Similarly, an antiandrogen such as Casodex TM or Flutemide TM can be administered. Enhancement of smooth muscle tone can be achieved with sustained-released alpha 1 agonist administration that is usually packaged along with an antihistamine.…”

Section: Therapy For Low¯ow Priapismmentioning

confidence: 99%

Priapism

Melman

Serels

2000

Int J Impot Res

View full text Add to dashboard Cite

“…Recently, very unusual cases of priapism occurring in hypogonadal men receiving pulsatile GnRH therapy for hypogonadotrophic hypogonadism have been described (Whalen et al 1991). The investigators believe that priapism may have developed as a result of sudden exposure to testosterone after prolonged deprivation and/or a diDrug Safety 8 (4) /993 minished threshold response to the androgen hormone.…”

Section: What Is Disease Flare and Its Importance?mentioning

confidence: 99%